Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
KUALA LUMPUR, Jan 22 (Bernama) -- Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune joint pain, with women said to be two to ...